Selective insulin resistance in the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 9, 1999, Pages 3110-3116

  Book, Carol Beth ^b   Dunaif, Andrea ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN; INOSITOL DERIVATIVE; INSULIN; INSULIN RECEPTOR; PHOSPHOTRANSFERASE; SOMATOMEDIN C; THYMIDINE;

ADULT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN BINDING; INSULIN METABOLISM; INSULIN RESISTANCE; MITOGENESIS; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL PROCESSING; SKIN FIBROBLAST;

FALLOPIA;

EID: 0033304892     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.9.3110     Document Type: Article

References (57)

1. Insulin resistance and the polycystic ovary syndrome: Mechanisms and implications for pathogenesis
2. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study
3. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome
4. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
5. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
6. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism
7. Insulin-like factors and insulin: Comparative aspects
8. Specificity spillover at the hormone receptor-exploring its role in human disease
9. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor
10. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system
11. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: A possible link to insulin resistance?
12. The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action
13. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
14. Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling?
15. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase
16. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipoysis in rat adipocytes
17. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation
18. Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle. Comparison with fat cells
19. New insights into the role and mechanism of glycogen synthase activation by insulin
20. Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties
21. Insulin-mediated pseudoacromegaly: Clinical and biochemical characterization of a syndrome of selective insulin resistance
22. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for abnormality specific to glucose metabolism
23. Insulin activates glycogen synthase in cultured human fibroblasts
24. Insulin binding, internalization, and insulin receptor regulation in fibroblasts from type II, non-insulin-dependent diabetic subjects
25. Autophosphorylation of cultured skin fibroblast insulin receptors from patients with severe insulin resistance and acanthosis nigricans
26. Acquired defects of glycogen synthase activity cultured human skeletal muscle cells
27. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects
28. Absence of insulin receptor gene mutations in three women with the polycystic ovary syndrome
29. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the polycystic ovary syndrome
30. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia
31. Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome
32. Evidence for distinctive and intrinsic defects in insulin action in the polycystic ovary syndrome
33. Insulin resistance in polycystic ovary syndrome: Decreased expression of GLUT4 glucose transporters in adipocytes
34. B-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome
35. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples
36. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
37. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
38. Clarification of signaling pathways mediated by insulin and insulin-like growth factor I receptors in fibroblasts from patients with specific defect in insulin receptor
39. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: Clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts
40. Rat fibroblast cells overexpressing kinase-inactive human insulin receptors are insulin responsive: Influence of growth conditions
41. Activation of phosphatidylinositol 3-kinase by insulin
42. Insulin stimulation of phosphatidylinositol 3-kianse activity maps to insulin receptor regions required for endogenous substrate phosphorylation
43. Formation of phosphatidylinositol 3-phosphate by insomerization from phosphatidylinositol 4-phosphate
44. Reversability of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss
45. Glucose and insulin regulate insulin sensitivity in primary cultured adipocytes without affecting insulin receptor kinase activity
46. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: Effects of diet treatment
47. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
48. Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome
49. Decline in insulin-like growth factor I levels after clomiphene citrate does not correct hyperandrogenemia in polycystic ovary syndrome
50. Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly
51. Increased hexosamine availability similarly impairs the action of insulin and IGF-I on glucose disposal
52. Defective insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
53. Disruption of IRS-2 causes type 2 diabetes in mice
54. Masculinization: A clinical approach to the diagnosis and treatment of hyperandrogenic women
55. Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance
56. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects
57. Evidence for a genetic basis for hyperandrogenemia in the polycystic ovary syndrome